Takeyama R

No ORCID on file · 5 papers in corpus · active 2019-2025

Study types

  • article 3

Condition tags

  • endometriosis 3
  • infertility 1
  • adenomyosis 1
2025
Expression of NKp46 and other activating inhibitory receptors on uterine endometrial NK cells in females with various reproductive failures: A review.
Reproductive medicine and biology ·doi:10.1002/rmb2.12610

BackgroundUterine endometrial natural killer (uNK) cells represent major leukocytes in the mid-secretory phase of the cell cycle, and their number is further increased during early pregnancy. The activating and inhibitory receptors expresse…

article 2022
Co-expression of activating and inhibitory receptors on peritoneal fluid NK cells in women with endometriosis
Journal of reproductive immunology ·doi:10.1016/j.jri.2022.103765

The detailed mechanism underlying endometriosis development remains unclear; few reports have suggested the involvement of immune and genetic factors. This study aims to investigate the role of NK cells in endometriosis by analyzing the co-…

2020
KRAS mutations in uterine endometrium are associated with gravidity and parity.
Cell death & disease ·doi:10.1038/s41419-020-2559-0
article 2020
Pelvic endometriosis and natural killer cell immunity
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.13342

Endometriosis is a chronic disease that commonly affects women in their reproductive age. It has been reported that the infertility due to endometriosis is largely caused by pelvic adhesion, oocyte damage, and so on. There are several cause…

article 2019
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations
Nature communications ·doi:10.1038/s41467-019-13708-y

Uterine adenomyosis is a benign disorder that often co-occurs with endometriosis and/or leiomyoma, and impairs quality of life. The genomic features of adenomyosis are unknown. Here we apply next-generation sequencing to adenomyosis (70 ind…